These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30400755)
1. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line. Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755 [TBL] [Abstract][Full Text] [Related]
2. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597 [TBL] [Abstract][Full Text] [Related]
3. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression. Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615 [TBL] [Abstract][Full Text] [Related]
4. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer. Shang Y; Feng B; Zhou L; Ren G; Zhang Z; Fan X; Sun Y; Luo G; Liang J; Wu K; Nie Y; Fan D Oncotarget; 2016 Jan; 7(1):538-49. PubMed ID: 26623719 [TBL] [Abstract][Full Text] [Related]
5. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related. Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells. Wu B; Xing C; Tao J J Orthop Surg Res; 2019 Nov; 14(1):398. PubMed ID: 31779647 [TBL] [Abstract][Full Text] [Related]
7. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396 [TBL] [Abstract][Full Text] [Related]
8. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer. Sun T; Yang M; Chen S; Balk S; Pomerantz M; Hsieh CL; Brown M; Lee GM; Kantoff PW Prostate; 2012 Jul; 72(10):1093-103. PubMed ID: 22127852 [TBL] [Abstract][Full Text] [Related]
9. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma. Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718 [TBL] [Abstract][Full Text] [Related]
10. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer. Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells. Armstrong CM; Liu C; Lou W; Lombard AP; Evans CP; Gao AC Prostate; 2017 Jun; 77(9):1020-1028. PubMed ID: 28485104 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1. Yin JJ; Cheng XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356 [TBL] [Abstract][Full Text] [Related]
14. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. Ishihara T; Seki N; Inoguchi S; Yoshino H; Tatarano S; Yamada Y; Itesako T; Goto Y; Nishikawa R; Nakagawa M; Enokida H J Urol; 2014 Dec; 192(6):1822-30. PubMed ID: 25014580 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55. You B; Zhang KC Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1. Lu K; Liu C; Tao T; Zhang X; Zhang L; Sun C; Wang Y; Chen S; Xu B; Chen M FEBS Lett; 2015 Jun; 589(13):1485-90. PubMed ID: 25936765 [TBL] [Abstract][Full Text] [Related]
17. Micro-ribonucleic acid expression signature of metastatic castration-resistant prostate cancer: Regulation of NCAPH by antitumor miR-199a/b-3p. Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N Int J Urol; 2019 Apr; 26(4):506-520. PubMed ID: 30818424 [TBL] [Abstract][Full Text] [Related]
18. Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. Yang Z; Chen JS; Wen JK; Gao HT; Zheng B; Qu CB; Liu KL; Zhang ML; Gu JF; Li JD; Zhang YP; Li W; Wang XL; Zhang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):178. PubMed ID: 29216925 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression. Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310 [TBL] [Abstract][Full Text] [Related]
20. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3. Ding H; Sun Y; Hou Y; Li L Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]